Highlights Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Delayed NSE India S.E. Other stock markets 01:58:07 2024-05-09 EDT			5-day change	1st Jan Change
1,513 ^INR	-0.57%		-0.60%	+19.88%

05-04	Sun Pharmaceutical Industries Limited entered into an agreement to acquire Valstar Investment S.a. for an enterprise value of $31 million.	CI
04-29	Sun Pharmaceutical Industries Limited Company Receives an Order Passed by Jt. Commissioner, CGST and Central Excise	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sun Pharmaceutical Industries Limited entered into an agreement to acquire Valstar Investment S.a. for an enterprise value of $31 million.	05-03	CI
Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade	04-12	MT
Sun Pharmaceutical's Dadra, India Unit Gets 'Official Action Indicated' Status from US FDA	04-12	MT
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes	04-12	RE
Bausch wins US appeal to block Alvogen generic of diarrhea drug	04-11	RE
Sun Pharmaceutical's Acne Drug Gets Approval in Australia	03-19	MT
Sun Pharmaceutical Industries Limited Announces Approval of Winlevi in Australia	03-18	CI
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	02-29	MT
India pharma companies develop versions of Wegovy to get in on weight-loss windfall	02-22	RE
Sun Pharmaceutical Industries to Buy Minority Stake in Surgimatix	02-20	MT
Sun Pharmaceutical Industries Limited agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million.	02-19	CI
Pfizer agrees to pay $93 million to settle Lipitor antitrust lawsuit	02-14	RE
Indian Equities Close Higher Midweek, Led by Banking, IT Stocks	02-14	MT
Ex-dividend day for interim dividend	02-08	FA
Indian drugmaker Lupin beats quarterly profit estimates on strong demand	02-07	RE
Sun Pharmaceutical Industries Forms Unit for Business Expansion in UAE	02-06	MT
Lupin Gets US FDA Nod for Bromfenac Ophthalmic Solution	02-06	MT
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	02-06	RE
Sun Pharmaceutical Industries Forms New Subsidiary in US	02-06	MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	02-05	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Highlights

Filters